Brinker Capital Investments, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brinker Capital Investments, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,977,560
+88.9%
34,755
+31.3%
0.04%
+77.3%
Q3 2022$1,047,000
+408.3%
26,471
+466.0%
0.02%
+450.0%
Q2 2022$206,000
-1.0%
4,677
-10.2%
0.00%
+33.3%
Q1 2022$208,000
-80.1%
5,208
-77.3%
0.00%
-82.4%
Q3 2021$1,044,0000.0%22,9860.0%0.02%
+21.4%
Q2 2021$1,044,000
+43.8%
22,986
+32.0%
0.01%
+27.3%
Q1 2021$726,000
+14420.0%
17,413
+5685.0%
0.01%
Q4 2019$5,0003010.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders